Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.
Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check5 days agoChange DetectedNo additions or deletions were observed on the study page; core study information remains the same. If any minor visual adjustments exist, they do not affect the main content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%
- Check41 days agoChange DetectedCore page content is largely unchanged; however, several MedlinePlus topics were removed and the page version updated to v3.1.0, indicating a cleanup of topics rather than addition of new content.SummaryDifference0.7%
- Check55 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the 'Back to Top' link.SummaryDifference0.3%
- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as new information on drug safety and therapeutic classifications related to Vilazodone. Notably, the previous version's references to certain drug classifications and the specific mention of Vilazodone hydrochloride have been removed.SummaryDifference7%
Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.